The CDC recommends Neuraminidase inhibitors for the treatment of hospitalized patients and outpatients at risk for complications from influenza. It is important to counsel patient on the potential adverse effects of the medications. In general the agents will shorten the duration of symptoms by 14-16 hours but can produce headache, nausea vomiting and even psychiatric symptoms.